Results for tag: "Soft Tissue Infection Drug"

The Soft Tissue Infection Drug market is a subset of the Infectious Diseases Drugs market. It includes drugs used to treat infections of the skin, subcutaneous tissue, and fascia. These drugs are used to treat a variety of infections, including abscesses, cellulitis, and necrotizing fasciitis. They are typically administered orally, intravenously, or topically. Commonly used drugs include antibiotics, antifungals, antivirals, and antiseptics. The Soft Tissue Infection Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, and Johnson & Johnson. Show Less Read more